Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario Nuestra Señora de Candelaria (3)

2024

  1. The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

    Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1779-1789

2012

  1. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial

    The Lancet Oncology, Vol. 13, Núm. 3, pp. 239-246

2003

  1. Gemcitabine/vinorelbine in metastatic breast cancer patients previously treated with anthracyclines: Results of a phase II trial

    Clinical Breast Cancer, Vol. 4, Núm. 1, pp. 46-50